Concepedia

Qunling Zhang

QZ

Statistics

Publications

28

Citations

1.5K

H-Index

22

Active since

2008

Affiliations

Fudan University Shanghai Cancer Center(Current)

Shanghai Medical College of Fudan University

Fudan University

Shanghai Institute of Hematology

Shanghai Jiao Tong University

Qunling Zhang is an author at Fudan University Shanghai Cancer Center specializing in oncology, medicine, and molecular oncology.

Publications per year

2008–2024

28

Publications

28

Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple-negative breast cancer

Xichun Hu, Jian Zhang, Binghe Xu et al. · International Journal of Cancer · 2014 · 269 citations · Full text

, , +17

PI3K pathway activation results in low efficacy of both trastuzumab and lapatinib

Leiping Wang, Qunling Zhang, Jian Zhang et al. · BMC Cancer · 2011 · 145 citations · Full text

, , +17

Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)

Yunpeng Yang, Ting Zhou, Xiaozhong Chen et al. · Journal for ImmunoTherapy of Cancer · 2021 · 95 citations · Full text

, , +17

Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents

Kai Xue, Juan Gu, Qunling Zhang et al. · Journal of Cancer Research and Clinical Oncology · 2015 · 88 citations · Full text

, , +16

Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells

Ying Lu, Bing Chen, Junhong Song et al. · Proceedings of the National Academy of Sciences · 2013 · 84 citations · Full text

, , +17

1–5 of 28